[HTML][HTML] Aedes aegypti and Aedes albopictus (Diptera: Culicidae) ecology, biology, behaviour, and implications on arbovirus transmission in Thailand
A Ahebwa, J Hii, KB Neoh, T Chareonviriyaphap - One Health, 2023 - Elsevier
Aedes aegypti and Aedes albopictus (Aedes) transmit highly pathogenic viruses such as
dengue, chikungunya, yellow fever, and Zika which can cause life-threatening diseases in …
dengue, chikungunya, yellow fever, and Zika which can cause life-threatening diseases in …
Advances in computational methods to discover new NS2B-NS3 inhibitors useful against dengue and Zika viruses
IJ dos Santos Nascimento… - Current Topics in …, 2022 - ingentaconnect.com
The Flaviviridae virus family consists of the genera Hepacivirus, Pestivirus, and Flavivirus,
with approximately 70 viral types that use arthropods as vectors. Among these diseases …
with approximately 70 viral types that use arthropods as vectors. Among these diseases …
[HTML][HTML] Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells
H Bulstrode, GC Girdler, T Gracia, A Aivazidis… - Neuron, 2022 - cell.com
Zika virus (ZIKV) can infect human developing brain (HDB) progenitors resulting in epidemic
microcephaly, whereas analogous cellular tropism offers treatment potential for the adult …
microcephaly, whereas analogous cellular tropism offers treatment potential for the adult …
[HTML][HTML] An overview of Zika virus genotypes and their infectivity
LC Bernardo-Menezes, A Agrelli… - Revista da Sociedade …, 2022 - SciELO Brasil
Zika virus (ZIKV) is an enveloped, single-stranded RNA arbovirus belonging to the genus
Flavivirus. It was first isolated from a sentinel monkey in Uganda in 1947. More recently …
Flavivirus. It was first isolated from a sentinel monkey in Uganda in 1947. More recently …
[HTML][HTML] Natural compounds as non-nucleoside inhibitors of Zika virus polymerase through integration of in silico and in vitro approaches
Although the past epidemic of Zika virus (ZIKV) resulted in severe neurological
consequences for infected infants and adults, there are still no approved drugs to treat ZIKV …
consequences for infected infants and adults, there are still no approved drugs to treat ZIKV …
Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika
M Mottin, BK de Paula Sousa… - Journal of chemical …, 2022 - ACS Publications
The Zika virus (ZIKV) is a neurotropic arbovirus considered a global threat to public health.
Although there have been several efforts in drug discovery projects for ZIKV in recent years …
Although there have been several efforts in drug discovery projects for ZIKV in recent years …
[HTML][HTML] Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
Zika virus (ZIKV) infections are spreading silently with limited global surveillance in at least
89 countries and territories. There is a pressing need to develop an effective vaccine …
89 countries and territories. There is a pressing need to develop an effective vaccine …
[HTML][HTML] Congenital anomalies during the 2015–2018 Zika virus epidemic: a population-based cross-sectional study
FA Venancio, ME Quilião, D de Almeida Moura… - BMC Public Health, 2022 - Springer
Background Congenital anomalies are associated with several clinical and epidemiological
complications. Following the Zika epidemic onset in Latin America, the incidence of …
complications. Following the Zika epidemic onset in Latin America, the incidence of …
[HTML][HTML] Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness
JM Marano, J Weger-Lucarelli - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Introduction Flaviviruses like dengue virus (DENV) and Zika virus (ZIKV) are mosquito-borne
viruses that cause febrile, hemorrhagic, and neurological diseases in humans, resulting in …
viruses that cause febrile, hemorrhagic, and neurological diseases in humans, resulting in …
Preexisting inter-serotype immunity drives antigenic evolution of dengue virus serotype 2
JM Marano, J Weger-Lucarelli - Virology, 2024 - Elsevier
Dengue virus (DENV) infects roughly 400 million people annually, causing febrile and
hemorrhagic disease. While preexisting inter-serotype immunity (PISI) provides transient …
hemorrhagic disease. While preexisting inter-serotype immunity (PISI) provides transient …